Chemists from ETH Zurich have found a way to produce poorly soluble proteins by caging a uniquely reactive boron compound. This method opens up new possibilities for the synthesis of tailored protein ...

The breakthrough could simplify the production of complex proteins used in cancer immunotherapy and other advanced medicines ...

Drug discovery is like molecular Tetris. Chemists snap atoms together, adjusting the pieces until everything fits and suddenly, a molecule makes a promising new medicine. Normally, creating better ...

Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Organometallics Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Organometallics ...

Many of the key proteins for modern medicine and science are poorly soluble. These include numerous signalling proteins and protein hormones, as well ...

Chemists from ETH Zurich have found a way to produce poorly soluble proteins by caging a uniquely reactive boron compound. This method opens up new possibilities for the synthesis of tailored protein ...

Market To Reach US$ 251.2 Million By 2033 Driven By Food & Beverage And Chemical Industry Demand. EINPresswire/ -- The global dimethyl sulfide (DMS) market is poised for robust growth in the coming ...

Lack of sleep harms almost every system in the body: From concentration and memory to hunger hormones, metabolism and the ability to cope with stress.

A 3D model of a sheet of hydrocarbon chains that form a honeycomb pattern. Each side of the honeycomb contains three benzene rings with short linkers between them. A new covalent organic framework is ...

Scientists from Skoltech, the Nikolaev Institute of Inorganic Chemistry SB RAS, and other Russian research institutions have shown that a double perovskite BaYNbO, is suitable for a thermal barrier ...

Researchers identified more than 200 metabolic enzymes attached to human DNA, forming unique nuclear metabolic fingerprints across tissues and cancers.

Study data from patients with relapsed or refractory gynecologic cancers signals the potential of LYMPHIR to augment immune checkpoint inhibitor efficacy Topline data ...